The Immunoregulatory Potential of Particle Radiation in Cancer Therapy
Open Access
- 6 February 2017
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 8, 99
Abstract
Cancer treatment consists today of surgery, chemotherapy, radiation, and most recently immunotherapy. Combination immunotherapy-radiotherapy (CIR) has experienced a surge in public attention due to numerous clinical publications outlining the reduction or elimination of metastatic disease following treatment with specifically ipilimumab and radiotherapy. The mechanism behind CIR, however, remains unclear, though it is hypothesized that radiation transforms the tumor into an in-situ vaccine, which immunotherapy modulates into a larger immune response. To date, the majority of attention has focused on rotating out immunotherapeutics with conventional radiation; however, the unique biological and physical benefits of particle irradiation may prove superior in generation of systemic effect. Here, we review recent advances in CIR, with a particular focus on the usage of charged particles to induce or enhance response to cancerous diseaseKeywords
Funding Information
- Instituto Nazionale di Fisica Nucleare (Call CSN5 MoVeIT project)
This publication has 59 references indexed in Scilit:
- p53-independent early and late apoptosis is mediated by ceramide after exposure of tumor cells to photon or carbon ion irradiationBMC Cancer, 2013
- Combining Radiotherapy and Cancer Immunotherapy: A Paradigm ShiftJNCI: Journal of the National Cancer Institute, 2013
- Immunologic Correlates of the Abscopal Effect in a Patient with MelanomaNew England Journal of Medicine, 2012
- The convergence of radiation and immunogenic cell death signaling pathwaysFrontiers in Oncology, 2012
- Systemic effects of local radiotherapyThe Lancet Oncology, 2009
- TGF-β: A Master of All T Cell TradesCell, 2008
- DNA Damage, Apoptosis and Langerhans Cells—Activators of UV‐induced Immune Tolerance†Photochemistry and Photobiology, 2008
- Cyclooxygenases, prostanoids, and tumor progressionCancer and Metastasis Reviews, 2007
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- The sensitivity of lymphocytes to ionising radiationThe Journal of Pathology and Bacteriology, 1952